CN105687543A - External Chinese herba preparation for treating tumors - Google Patents

External Chinese herba preparation for treating tumors Download PDF

Info

Publication number
CN105687543A
CN105687543A CN201610155256.9A CN201610155256A CN105687543A CN 105687543 A CN105687543 A CN 105687543A CN 201610155256 A CN201610155256 A CN 201610155256A CN 105687543 A CN105687543 A CN 105687543A
Authority
CN
China
Prior art keywords
grams
parts
radix
herba
chinese
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610155256.9A
Other languages
Chinese (zh)
Inventor
王冶
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201610155256.9A priority Critical patent/CN105687543A/en
Publication of CN105687543A publication Critical patent/CN105687543A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/489—Sophora, e.g. necklacepod or mamani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/288—Taraxacum (dandelion)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/34—Campanulaceae (Bellflower family)
    • A61K36/344—Codonopsis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/35—Caprifoliaceae (Honeysuckle family)
    • A61K36/355—Lonicera (honeysuckle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/539—Scutellaria (skullcap)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/57—Magnoliaceae (Magnolia family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/708—Rheum (rhubarb)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/79—Schisandraceae (Schisandra family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/86—Violaceae (Violet family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to an external Chinese herba preparation for treating tumors. The problems that existing traditional Chinese and Western medicine treatment modes are large in side effect and poor in treatment effect are mainly solved. The external Chinese herba preparation is characterized by being prepared from, by weight, 30-40 parts of radix sophorae subprostratae, 30-40 parts of ligusticum wallichii, 30-40 parts of concha ostreae, 30-40 parts of barbed skullcap herbs, 10-20 parts of java brucea fruit, 10-20 parts of crocus sativus, 30-40 parts of garden balsam stems, 10-20 parts of honeysuckle flowers, 30-40 parts of dandelions, 10-20 parts of herba corydalis bungeanae, 50-60 parts of herba patriniae, 10-20 parts of castor-oil plants, 35-45 parts of radix angelicae, 30-40 parts of rheum officinale, 30-40 parts of hairyvein agrimonia herbs and buds, 35-45 parts of Chinese magnoliavine fruit, 10-20 parts of radix codonopsis, 15-25 parts of radix angelica sinensis, 30-40 parts of herba taxilli, 30-40 parts of radix salviae miltiorrhizae, 30-40 parts of pseudo-ginseng, 40-50 parts of liquorice roots, 30-40 parts of radix achyranthis bidentatae and 10-20 parts of radix stephaniae tetrandrae. The external Chinese herba preparation for treating tumors does not injure viscus organs and is safe, reliable, good in treatment effect, free of toxic and side effects and low in cost, and the tumors are not prone to relapse.

Description

A kind of Chinese medicine for outer use treating tumor
Technical field
The present invention relates to the field of Chinese medicines, particularly to a kind of Chinese medicine for outer use treating tumor。
Background technology
Tumor be body under various carcinogenic factor effects, some cell of local organization loses the normal regulation to its growth on gene level, causes its clonal abnormality hypertrophy and the neoplasm that formed, and tumor is generally divided into benign tumor and malignant tumor。Malignant tumor can destroy the 26S Proteasome Structure and Function of tissue, organ, is one of the commonly encountered diseases and frequently-occurring disease of serious threat human health up to now, finds effective antitumour medicine and method, thoroughly captures the important subject that malignant tumor is world medical circle。
At present, clinically the treatment of tumor be there is no particularly effective method, tumor that western medical treatment " stasis of blood " " blocking up " is formed, hypertrophy, the Therapeutic Method that the disease such as blocks are excisions and use hormone therapy, existing Therapeutic Method toxic and side effects is big, wound is big, often the misery of heavy patient is added, curing the symptoms, not the disease, treatment cost is high, effect is undesirable。Though traditional Chinese medical science oral Chinese medicine takes stopgap measures and effects a permanent cure, but digesting and assimilating through internal organs, drain, not only drug effect is not played well, and internal organs are easily impaired, has been not fee from side effect equally。
Summary of the invention
The invention reside in and overcome what background technology existed to adopt the problem that existing integrative therapy mode side effect big therapeutic effect difference cost is high, and a kind of Chinese medicine for outer use treating tumor is provided, the Chinese medicine for outer use of this treatment tumor, do not damage internal organs organ, safe and reliable, good effect, no side effects, not easily recurs, with low cost。
This invention address that its problem can reach by following technical solution: a kind of Chinese medicine for outer use treating tumor, the weight portion of its component and each component is: Radix Sophorae Tonkinensis 30-40 part, Rhizoma Chuanxiong 30-40 part, Concha Ostreae 30-40 part, Herba Scutellariae Barbatae 30-40 part, Fructus Bruceae 10-20 part, Stigma Croci 10-20 part, Herba speranskiae tuberculatae 30-40 part, Flos Lonicerae 10-20 part, Herba Taraxaci 30-40 part, Herba Violae 10-20 part, Herba Patriniae 50-60 part, Semen Ricini 10-20 part, Radix Angelicae Dahuricae 35-45 part, Radix Et Rhizoma Rhei 30-40 part, Herba Agrimoniae 30-40 part, Fructus Schisandrae Chinensis 35-45 part, Radix Codonopsis 10-20 part, Radix Angelicae Sinensis 15-25 part, Herba Taxilli 30-40 part, Radix Salviae Miltiorrhizae 30-40 part, Radix Notoginseng 30-40 part, Radix Glycyrrhizae 40-50 part, Radix Achyranthis Bidentatae 30-40 part, Radix Stephaniae Tetrandrae 10-20 part。
Effect of the Chinese medicine for outer use each composition of employing of this treatment tumor is as follows:
Main medicine: Radix Sophorae Tonkinensis heat-clearing and toxic substances removing, reducing swelling and alleviating pain；Rhizoma Chuanxiong warming the meridian and activating blood circulation, promotes microcirculation；Concha Ostreae YANG hyperactivity suppressing is astringent or styptic treatment for spontaneous sweating, resolving phlegm and softening hard masses, and antacid is anticancer；Herba Scutellariae Barbatae heat-clearing and toxic substances removing, blood circulation promoting and blood stasis dispelling, inducing diuresis to remove edema；Fructus Bruceae blood fat reducing, leukocyte increasing, antitumor；Stigma Croci blood circulation promoting and blood stasis dispelling, stimulates the menstrual flow and nourishes blood；Herba speranskiae tuberculatae wind-damp dispelling, broken knot, promoting blood circulation and stopping pain。
Adjuvant: Flos Lonicerae heat-clearing and toxic substances removing, adjustment heat center；The detumescence of Herba Taraxaci, Herba Violae removing heat from blood, eliminating stagnation；Herba Patriniae heat-clearing and toxic substances removing, promoting blood circulation and breaking stagnation, eliminating carbuncle pain relieving, anti-atherosclerosis；Semen Ricini loosening bowel to relieve constipation, detumescence of drawing out pus by applying a plaster to the affected part, invigorate blood circulation anticancer；The Radix Angelicae Dahuricae deliver dispel the wind, promoting blood circulation and stopping pain；Radix Et Rhizoma Rhei heat-clearing and toxic substances removing, removing mass stomach invigorating, blood circulation promoting and blood stasis dispelling；Herba Agrimoniae anthelmintic thrombocytosis, antitumor。
Hold concurrently pharmacy: Fructus Schisandrae Chinensis anti-inflammation, dredge the meridian passage, adjustment blood pressure balance, strong physical ability, allaying tiredness, anticancer；In Radix Codonopsis QI invigorating benefit, hemopoietic of enriching blood；Chinese angelica blood supplementing is invigorated blood circulation, menstruction regulating and pain relieving, blood stasis dispelling are strong；Herba Taxilli wind-damp dispelling, invigorating the liver and kidney, anticancer growth；Radix Salviae Miltiorrhizae promoting blood flow to regulate menstruation, promoting tissue regeneration by removing blood stasis；Pseudo-ginseng blood-circulation-invigovating hemostasis, removing blood stasis with potent drugs pain relieving, thrombocytosis blood fat reducing。
Draw and medicine: Radix Glycyrrhizae heat-clearing and toxic substances removing, invigorating the spleen and replenishing QI, coordinating the actions of various ingredients in a prescription；Radix Achyranthis Bidentatae promoting blood circulation to restore menstrual flow, dissipating blood stasis；Radix Stephaniae Tetrandrae expelling wind and removing dampness, promoting the circulation of QI to relieve pain, parasite killing antitumor, pass through blood brain barrier, pure grain ethanol row medicine gesture, promoting blood circulation。
The process for preparation of the Chinese medicine for outer use of this treatment tumor:
1. dispensing: medicine weighs mixing after accurately and is divided into coarse powder, prepares the ethanol of 60 degree and glass or rustless steel container。
2. Chinese medicine powder is poured in container, then pour into 20 times of medicated powder 60 degree soak with ethanol 5-10 days, when ambient temperature 20 degree soak 7 days, can reduce when ambient temperature is higher or lower than 20 degree or increase invade steep 1-3 days time。
The present invention can have the advantages that compared with above-mentioned background technology the Chinese medicine for outer use of this treatment tumor is pure Chinese medicinal preparation, theoretical according to Chinese medicine inner disease outer treat provides a kind of " Chinese medicine liniment for external application ", this liniment ethanol does solvent soaking numerical digit Chinese herbal medicine and forms, it is for the medication on the acupuncture point that skin is different of different diseases, liniment make simple, easy to use, not entrance, do not damage internal organs organ, safe and reliable, curative effect is fast, and short treating period, cure rate are high, do not recur。Diseases such as treating human body intestinal cancer caused by " stasis of blood " " blocking up ", esophageal carcinoma, gastric cancer, breast carcinoma, cyclomastopathy, hepatocarcinoma, liver cirrhosis, hepatic ascites, (de-scaling cancer and adenocarcinoma) pulmonary carcinoma, cervical cancer, cerebral infarction, cerebroma, soft tissue hyperplasia, decubital ulcer, cervical spondylosis is had the curative effect of uniqueness, especially treatment cyclomastopathy instant effect by this medicine。The pure herbal pharmaceutical external of this medicine has no side effect, and dredge the meridian passage, carries and poisons the stasis of blood, relaxing muscles and tendons to promote blood circulation。The Chinese medicine for outer use effective percentage 100% of this treatment tumor, cure rate 80-90%。
Detailed description of the invention:
Below in conjunction with detailed description of the invention, the present invention is further illustrated:
Embodiment 1
Weigh Radix Sophorae Tonkinensis 4 grams, Rhizoma Chuanxiong 4 grams, Concha Ostreae 3.8 grams, Herba Scutellariae Barbatae 4 grams, Fructus Bruceae 2 grams, Stigma Croci 2 grams, Herba speranskiae tuberculatae 4 grams, Flos Lonicerae 1.5 grams, Herba Taraxaci 3.8 grams, Herba Violae 2 grams, Herba Patriniae 5.8 grams, Semen Ricini 1.5 grams, the Radix Angelicae Dahuricae 4.5 grams, Radix Et Rhizoma Rhei 4 grams, Herba Agrimoniae 3.8 grams, Fructus Schisandrae Chinensis 4.5 grams, Radix Codonopsis 2 grams, Radix Angelicae Sinensis 2 grams, Herba Taxilli 4 grams, Radix Salviae Miltiorrhizae 4 grams, Radix Notoginseng 4 grams, 5 grams of Radix Glycyrrhizae, Radix Achyranthis Bidentatae 3.8 grams, Radix Stephaniae Tetrandrae 1.8 grams, it is introduced directly in glass container after all medicine co-grinding coarse powder, it is subsequently adding 2.9 jin of 60 degree of ethanol, after steeping postprecipitation filtration in 7 days under 20 degree of room temperature environments, take 1000 milliliters of medicinal liquid bottlings to use。
Embodiment 2
Weigh Radix Sophorae Tonkinensis 3 grams, Rhizoma Chuanxiong 3 grams, Concha Ostreae 3 grams, Herba Scutellariae Barbatae 3 grams, Fructus Bruceae 1 gram, Stigma Croci 1.5 grams, Herba speranskiae tuberculatae 3 grams, Flos Lonicerae 1.5 grams, Herba Taraxaci 3 grams, Herba Violae 1.5 grams, Herba Patriniae 5 grams, Semen Ricini 1.5 grams, the Radix Angelicae Dahuricae 3.5 grams, Radix Et Rhizoma Rhei 3 grams, Herba Agrimoniae 3 grams, Fructus Schisandrae Chinensis 4 grams, Radix Codonopsis 1.5 grams, Radix Angelicae Sinensis 1.5 grams, Herba Taxilli 3 grams, Radix Salviae Miltiorrhizae 3.5 grams, Radix Notoginseng 3 grams, 4 grams of Radix Glycyrrhizae, Radix Achyranthis Bidentatae 3.5 grams, Radix Stephaniae Tetrandrae 1.5 grams, it is introduced directly in glass container after all medicine co-grinding coarse powder, it is subsequently adding 2.9 jin of 60 degree of ethanol, after steeping postprecipitation filtration in 7 days under 20 degree of room temperature environments, take 1000 milliliters of medicinal liquid bottlings to use。
Embodiment 3
Weigh Radix Sophorae Tonkinensis 3.5 grams, Rhizoma Chuanxiong 3.5 grams, Concha Ostreae 3.5 grams, Herba Scutellariae Barbatae 3.5 grams, Fructus Bruceae 1.5 grams, Stigma Croci 1.5 grams, Herba speranskiae tuberculatae 3.5 grams, Flos Lonicerae 1.5 grams, Herba Taraxaci 3.5 grams, Herba Violae 1.5 grams, Herba Patriniae 5.5 grams, 1.5 grams of Radixs Angelicae Dahuricae of Semen Ricini 4.0 grams, Radix Et Rhizoma Rhei 3.5 grams, Herba Agrimoniae 3.5 grams, Fructus Schisandrae Chinensis 4.0 grams, Radix Codonopsis 1.5 grams, Radix Angelicae Sinensis 2.0 grams, Herba Taxilli 3.5 grams, Radix Salviae Miltiorrhizae 3.5 grams, Radix Notoginseng 3.5 grams, 4.5 grams of Radix Glycyrrhizae, Radix Achyranthis Bidentatae 3.5 grams, Radix Stephaniae Tetrandrae 1.5 grams, it is introduced directly in glass container after all medicine co-grinding coarse powder, it is subsequently adding 2.9 jin of 60 degree of ethanol, after steeping postprecipitation filtration in 7 days under 20 degree of room temperature environments, take 1000 milliliters of medicinal liquid bottlings to use。
Using method: take appropriate liniment hands and dip in and rub Baihui acupoint and body part diseased region a little, three times on the one, (1) each Baihui acupoint consumption 3 milliliters, rub the Baihui acupoint time about 10 minutes, (2) each diseased region consumption 3-7 milliliter, the time of rubbing is 15-40 minute, (3) total consumption every day is less than 30 milliliters, (4) cerebral infarction and cerebroma are only used at head Baihui acupoint, (5) life cycle is 33 days, consumption 1000 milliliters, slight patient's cure rate 90% such as general hypertrophy, cerebral infarction, cancer patient takes an evident turn for the better, improvement rate 100%。
Model case:
Case 1: patient: Xu certain, female, people from Harbin, 60 years old, in July, 2010, operation of lung cancer, started with liniment in January, 2011, and in March, 2011 checks that cancerous cell does not have, and in June, 2011 checks health, and indices is normal, shares 2000 milliliters of liniments。
Case 2: patient: Lee, man, people from Daqing, 50 years old, in February, 2011, liver cirrhosis turned hepatocarcinoma, started in April, 2011 with liniment, on June 1st, 2011, examination in hospital, the quantitative normal value of hepatitis B virus, erythrocyte, platelet, leukocyte normal value, the thick footpath of spleen reduces 0.3 centimetre, major diameter reduces 0.5 centimetre, and patient lives normally so far。Share 2000 milliliters of liniments。
Case 3: patient: pay certain, man, people from Daqing, civil servant, 49 years old, health check-up in March, 2012 went out virus to liver cirrhosis, begins to use liniment in November, 2012, health check-up in April, 2013, indices is normal, and patient uses altogether 2000 milliliters of liniments, is in a good state of health at present, simply use liniment once in a while, need not use every day again。
Case 4: patient: Deng, man, Jixi City people, 80 years old, within 2015, December found Gerontal gastric cancer on 3rd, hospital says that patient can only live one month, within 2015, December begins to use liniment on the 11st, and current patient has a meal, defecation is all normal, and hospital also admits that this is miracle, one shares liniment 2000 milliliters, simply uses liniment once in a while at present。
Case 5: patient: Zhang, female, people from Daqing, hospital nurse, 40 years old, within 2012, go out cyclomastopathy at grand celebration examination in hospital, hospital's suggestion operative treatment, patient's initiative uses liniment, and with liniment less than 2000 milliliters, hypertrophy disappears, and patient fully recovers。
Case 6: Liu: man, within 41 years old, in December, 2015 trouble takes by storm cerebral infarction hospitalization, and after 1 month, blood glucose raises, heart attack, and cerebral infarction is not thoroughly cured, and with liniment 2000 milliliters recovery from illness after leaving hospital, all goes well so far。
Case 7: patient: go through certain, people from Harbin, 70 years old, find cerebral infarction many years ago, limited to health action, aphasia, sialorrhea, in JIUYUE, 2015 is with after liniment 2000 milliliters, and language is spoken and substantially changed than before, not sialorrhea。
Case 8: patient: Huang, people from Daliang City, 60 years old, cirrhotic ascites, in December, 2015 liniment, in February, 2016 was almost recovered, and one shares 2000 milliliters of liniments。
Case 9: patient: Xiao, people from Songyuan City, female 41 years old, in July, 2015 health check-up finds bilateral cyclomastopathy, starts in August, 2015 to use liniment, and in October, 2015 checks that hypertrophy disappears, and patient fully recovers, and shares 2000 milliliters of liniments。
Case 10: patient: Wu, Heihe City people, man, 60 years old, due to long-term paralysis, decubital ulcer was festered to leg, seeks medical advice and medicine in many places, does not heal throughout the year, in October, 2015 liniment, first quarter moon detumescence and promoting granulation, 30 days recovery from illness。

Claims (2)

1. the Chinese medicine for outer use treating tumor, it is characterized in that: the weight portion of its component and each component is: Radix Sophorae Tonkinensis 30-40 part, Rhizoma Chuanxiong 30-40 part, Concha Ostreae 30-40 part, Herba Scutellariae Barbatae 30-40 part, Fructus Bruceae 10-20 part, Stigma Croci 10-20 part, Herba speranskiae tuberculatae 30-40 part, Flos Lonicerae 10-20 part, Herba Taraxaci 30-40 part, Herba Violae 10-20 part, Herba Patriniae 50-60 part, Semen Ricini 10-20 part, Radix Angelicae Dahuricae 35-45 part, Radix Et Rhizoma Rhei 30-40 part, Herba Agrimoniae 30-40 part, Fructus Schisandrae Chinensis 35-45 part, Radix Codonopsis 10-20 part, Radix Angelicae Sinensis 15-25 part, Herba Taxilli 30-40 part, Radix Salviae Miltiorrhizae 30-40 part, Radix Notoginseng 30-40 part, Radix Glycyrrhizae 40-50 part, Radix Achyranthis Bidentatae 30-40 part, Radix Stephaniae Tetrandrae 10-20 part。
2. a kind of Chinese medicine for outer use treating tumor according to claim 1, it is characterised in that: the weight portion of its component and each component is: Radix Sophorae Tonkinensis 35 grams, Rhizoma Chuanxiong 35 grams, Concha Ostreae 35 grams, Herba Scutellariae Barbatae 35 grams, Fructus Bruceae 15 grams, Stigma Croci 15 grams, Herba speranskiae tuberculatae 35 grams, Flos Lonicerae 15 grams, Herba Taraxaci 35 grams, Herba Violae 15 grams, Herba Patriniae 55 grams, Semen Ricini 15 grams, the Radix Angelicae Dahuricae 40 grams, Radix Et Rhizoma Rhei 35 grams, Herba Agrimoniae 35 grams, Fructus Schisandrae Chinensis 40 grams, Radix Codonopsis 15 grams, Radix Angelicae Sinensis 20 grams, Herba Taxilli 35 grams, Radix Salviae Miltiorrhizae 35 grams, Radix Notoginseng 35 grams, 45 grams of Radix Glycyrrhizae, Radix Achyranthis Bidentatae 35 grams, Radix Stephaniae Tetrandrae 15 grams。
CN201610155256.9A 2016-03-18 2016-03-18 External Chinese herba preparation for treating tumors Pending CN105687543A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610155256.9A CN105687543A (en) 2016-03-18 2016-03-18 External Chinese herba preparation for treating tumors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610155256.9A CN105687543A (en) 2016-03-18 2016-03-18 External Chinese herba preparation for treating tumors

Publications (1)

Publication Number Publication Date
CN105687543A true CN105687543A (en) 2016-06-22

Family

ID=56231979

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610155256.9A Pending CN105687543A (en) 2016-03-18 2016-03-18 External Chinese herba preparation for treating tumors

Country Status (1)

Country Link
CN (1) CN105687543A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110507734A (en) * 2019-09-21 2019-11-29 王冶 A kind of Chinese medicine composition of auxiliary treatment of cervical carcinoma and preparation method thereof
CN110548123A (en) * 2019-09-21 2019-12-10 王冶 A Chinese medicinal composition for adjuvant treatment of liver cirrhosis and hepatocarcinoma, and its preparation method

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0665017A1 (en) * 1993-12-30 1995-08-02 Henne, Kurt Medicament for the prophylaxis and treatment of tumors
CN1422642A (en) * 2001-12-04 2003-06-11 何文法 Series Chinese medicinal composition for treating tumor
CN104857173A (en) * 2015-06-16 2015-08-26 陈列邦 External Chinese herbal preparation for cancer treatment and preparation method thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0665017A1 (en) * 1993-12-30 1995-08-02 Henne, Kurt Medicament for the prophylaxis and treatment of tumors
CN1422642A (en) * 2001-12-04 2003-06-11 何文法 Series Chinese medicinal composition for treating tumor
CN104857173A (en) * 2015-06-16 2015-08-26 陈列邦 External Chinese herbal preparation for cancer treatment and preparation method thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110507734A (en) * 2019-09-21 2019-11-29 王冶 A kind of Chinese medicine composition of auxiliary treatment of cervical carcinoma and preparation method thereof
CN110548123A (en) * 2019-09-21 2019-12-10 王冶 A Chinese medicinal composition for adjuvant treatment of liver cirrhosis and hepatocarcinoma, and its preparation method

Similar Documents

Publication Publication Date Title
CN103071128B (en) Externally-applied plaster for curing dysmenorrhea
CN102670961A (en) Chinese medicament for treating middle and old aged habitual constipation
CN104523865A (en) Medicine for treating breast diseases
CN102166278B (en) Chinese medicinal composition for treating pediatric rheumatoid arthritis and preparation method thereof
CN102988889B (en) Traditional Chinese medicine composition for treating hyperplasia of mammary glands
CN102100872A (en) Chinese medicine preparation for treating mastitis
CN101987138A (en) Chinese medicinal preparation for treating impotence
CN102048899A (en) Traditional Chinese medicine preparation for treating impotence
CN105687543A (en) External Chinese herba preparation for treating tumors
CN105434972A (en) Traditional Chinese medicine composition for treating breast hyperplasia
CN104771527A (en) Traditional Chinese medicine for treating varicosity
CN104027430B (en) A kind of Chinese medicine composition for the treatment of blood stasis type hysteromyoma
CN103550533B (en) Chinese medicine composition for treating headache during menstruation
CN102949544B (en) Chinese medicinal composition for specifically treating swelling of hands and feet of hemiplegic patients
CN105287949A (en) Traditional Chinese medicinal composition for treating dysmenorrhea
CN104001100A (en) Traditional Chinese medicine composition for treating PICC (Peripherally Inserted Central Catheter) phlebothrombosis and preparation method of traditional Chinese medicine composition
CN103223113B (en) Traditional Chinese medicine composition for treating functional uterine bleeding
CN110841007B (en) Traditional Chinese medicine composition for treating cerebral apoplexy sequela and application thereof
CN105663850A (en) Traditional Chinese medicine composition for treating oral ulcer
CN105687659A (en) Medicine patch for treating cesarean-postoperative abdominal incision sclerosis
CN105943643A (en) Aiwei pain relieving powder and preparation process thereof
CN105232661A (en) Traditional Chinese medicine composition for treating mastitis and preparation method thereof
CN104997912A (en) Oral medicine for effectively treating mammary gland hyperplasia, and preparation method thereof
CN104352773A (en) Traditional Chinese medicine preparation for treating chronic bronchitis and bronchial asthma
CN104274555A (en) Traditional Chinese medicine composition for treating rheumatism, ointment and preparation method of traditional Chinese medicine composition

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20160622

RJ01 Rejection of invention patent application after publication